Verified employee & interview reviews

Parexel India Reviews

Durham, North Carolina

4.3/ 5

3 reviews

Parexel India is a prominent contract research organization (CRO) and a critical operational hub of Parexel International, a leading global biopharmaceutical services provider. Established in India on November 11, 2006, as Parexel International (India) Private Limited, the company is an unlisted private entity headquartered in Hyderabad, Telangana, with its corporate office located at the Raheja Mindspace IT Park in Madhapur. Over the past two decades, Parexel India has grown significantly, expanding its presence to multiple key cities across the country, including Mohali, Chandigarh, and Bengaluru, and supporting a robust workforce of several thousand professionals. The core business activities of Parexel India revolve around providing comprehensive clinical development and biopharmaceutical services to global pharmaceutical, biotechnology, and medical device clients. These solutions are designed to accelerate the drug development life cycle and expedite the time-to-market for innovative therapies. The company operates through several specialized verticals, including clinical trial management, advanced data management, medical writing, biostatistics, regulatory affairs consulting, and pharmacovigilance (drug safety services). By integrating cutting-edge informatics with deep scientific expertise, Parexel India guides life science organizations through complex regulatory approval pathways, global clinical trials (from Phase I to Phase IV), and market access strategies. Financially, Parexel International (India) Private Limited operates with an authorized share capital of INR 30 crore and a paid-up capital of approximately INR 23.93 crore. The company represents a high-performing corporate unit, reporting an annual operating revenue exceeding INR 500 crore. Reflecting its corporate excellence, Parexel India has been recognized as a Great Place to Work-Certified™ organization, lauded for its workplace culture rooted in credibility, respect, fairness, pride, and camaraderie. The firm offers highly flexible, hybrid, and remote work arrangements to accommodate its extensive employee base. In addition to its core business operations, Parexel India maintains a strong commitment to Corporate Social Responsibility (CSR). The company actively collaborates with non-profit organizations, such as United Way and Smile Train India, to drive impactful community initiatives. Its CSR programs focus heavily on healthcare, sustainable development, and women's empowerment. Notable projects include sponsoring life-altering cleft reconstructive surgeries for underprivileged children and driving the Disha initiative, which provides vocational training in retail, textiles, and embroidery to women from marginalized backgrounds, establishing paths toward long-term financial independence. Globally, Parexel was acquired by EQT Private Equity and Goldman Sachs Asset Management in November 2021 for $8.5 billion, continuing its mission to transform scientific discoveries into life-saving treatments.